Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2016 ∙ Oligbu, G. Hsia, Y. Folgori, L. Collins, S. Ladhani, S.

Pneumococcal conjugate vaccine failure in children: A systematic review of the literature

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Burgess, L. Southern, K. W.

Pneumococcal vaccines for cystic fibrosis

  • Children
  • Adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2016 ∙ Herdman, M. Cole, A. Hoyle, C. K. Coles, V. Carroll, S. Devlin, N.

Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review

  • All age groups
  • Healthcare workers
  • Parents/caregivers
  • Hepatitis B
  • Hepatitis E
  • Measles
  • Meningococcal disease
  • Rotavirus
  • Varicella
  • Influenza
  • Pneumococcal disease
  • Economic aspects
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Ewald, H. Briel, M. Vuichard, D. Kreutle, V. Zhydkov, A. Gloy, V.

The Clinical Effectiveness of Pneumococcal Conjugate Vaccines A Systematic Review and Meta-analysis of Randomized Controlled Trials

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2016 ∙ Kraicer-Melamed, H. O'Donnell, S. Quach, C.

The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Voysey, M. Sadarangani, M. Clutterbuck, E. Bolgiano, B. Pollard, A. J.

The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials

  • Newborn
  • Haemophilus influenzae type B
  • Meningococcal disease
  • Pneumococcal disease
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Nicholls, T. R. Leach, A. J. Morris, P. S.

The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials

  • Newborn
  • Influenza
  • Pneumococcal disease
  • Streptococcus group B
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Health Council of the Netherlands

11th meeting of the Committee on Vaccination

  • Agenda & Minutes
  • Europe
  • Netherlands
  • Pneumococcal disease
Download:
2016 ∙ Ole Wichmann, E Hummers-Pradier, T Ledig, STIKO, Cornelius Remschmidt, Thomas Harder, G Falkenhorst, S Glodny, Christian Bogdan

Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany

  • Background paper
  • Europe
  • Germany
  • Pneumococcal disease
Download:
2016 ∙ CoPI

Recommendation on the Replacement of PCV-10 with PCV-13

  • Recommendation
  • Africa
  • Mozambique
  • Pneumococcal disease
Download:
Loading...